Keywords: AB Science, GIST, Masininib, Sutent, Pfizer

AB Science leaps as GIST candidate masitinib beats Sutent

Article | 06 February 2012

Print This

France-based AB Science (AB: EN Paris) saw its share price rocket as much as 72% to 10.60 euros after the company announced ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in